Walgreens Recalls L-Cysteine Syringes Due to Sterility Concerns
Walgreens Infusion Services is recalling 14 L-Cysteine 800 mg syringes in Texas because the agency could not ensure the product was sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (lack of sterility assurance) where injury has not yet been reported, which aligns with the High severity criteria.
Plain-English summary
Walgreens Infusion Services is recalling 14 syringes of L-Cysteine 800 mg (16 mL), prescription only, that were compounded by Option Care 148 in San Antonio, Texas. The recall is being conducted because the company lacks assurance of the sterility of the product.
The affected product was distributed in Texas. The recall covers all lots within the expiry date. The source text does not specify a particular lot number or expiration date.
Consumers who have this product should contact their healthcare provider or pharmacist for instructions on how to dispose of the medication or obtain a replacement. The source text does not report any illnesses or injuries associated with this recall.
The recalled product
- Product
- L-Cysteine 800 mg (16 mL) syringe, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045
- Manufacturer
- Walgreens Infusion Services
- Category
- Drug — Compounded Medication
- Hazard
- Affected units
- 14
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 33 recalled by Walgreens Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 33 products in this recall →Related recalls
Same manufacturer · Walgreens Infusion Services
See all →- SevereWalgreens Recalls IVIG Gamunex Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls Cefazolin Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls 0.9% Sodium Chloride/MVI Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Infusion Services Recalls Dextrose and Sodium Chloride Injection Bags
FDA (Drugs) · 2016-01-06
- HighWalgreens Recalls Famotidine Injection Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereWalgreens Recalls L-cysteine Infusions Due to Sterility Concerns
FDA (Drugs) · 2015-01-28
- SevereWalgreens Recalls Ranitidine Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-01-28
- SevereWalgreens Recalls Folic Acid Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-01-28
- SevereGuardian Pharmacy Recalls Hyaluronidase Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereWalgreens Recalls Thiamine Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-01-28
- SevereWalgreens Recalls Ceftriaxone Infusions Due to Sterility Concerns
FDA (Drugs) · 2015-01-28